Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
Global
Sandoz Site Directory
Our Work
What We Do
Disease Areas
Prescription Medicines
Over-The-Counter Medicines
Biopharmaceuticals
Partnerships and Collaborations
About Us
Who We Are
Corporate Responsibility
Doing Business Responsibly
Investor Information
Contact Us
News
All News
Media Releases
Publications
Media Library
Stay Up-To-Date
Media Contacts
Careers
Job Search
Working at Sandoz
Diversity & Inclusion
Making Access Happen
Access to Healthcare
Stories
Sandoz HACk
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2020
September
Featured News
/
Sep 02, 2020
US biosimilars five years on: Life on Mars?
Richard Saynor
vi
a LinkedIn
Read More
Media Release
/
Sep 01, 2020
New collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines
Read More
July
Featured News
/
Jul 28, 2020
Strengthening the future of antibiotics manufacturing in Europe
Richard Saynor via LinkedIn
Read More
Media Release
/
Jul 27, 2020
Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
Read More
Media Release
/
Jul 21, 2020
Novartis delivered strong H1 performance. FY 2020 guidance confirmed at higher end for core operating income and lower end for sales.
Read More
Media Release
/
Jul 13, 2020
Sandoz launches generic antibiotic Daptomycin in US, strategically growing injectables portfolio and strengthening hospital offering
Read More
Media Release
/
Jul 07, 2020
Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals
Read More
Featured News
/
Jul 07, 2020
Patient access through the looking glass?
Pierre Bourdage
vi
a LinkedIn
Read More
Media Release
/
Jul 01, 2020
Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case
Read More
June
Media Release
/
Jun 19, 2020
Novartis discontinues hydroxychloroquine clinical trial based on slow enrollment, remains committed to pandemic research efforts
Read More
Search Results Navigation
Current page
1
of 5
Page
2
of 5
Page
3
of 5
Page
4
of 5
Page
5
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Whatsapp
Jump to Comments
Print
Save
You are here
Home
›
News
›
